上海交通大学学报（医学版）

上海交通大学学报（医学版） ›› 2020, Vol. 40 ›› Issue (4): 548-.doi: 10.3969/j.issn.1674-8115.2020.04.023

• 综述 • 上一篇    下一篇

白细胞介素 -11对肿瘤促进作用的研究进展

潘德燊1, 2，李 登1，邵 怡1   

  1. 1. 上海交通大学附属第一人民医院泌尿外科，上海200080；2. 上海交通大学附属第一人民医院临床医学院，上海200080
  • 出版日期:2020-04-28 发布日期:2020-05-22
  • 通讯作者: 邵 怡，电子信箱：drshaoyi@163.com。
  • 作者简介:潘德燊（1998—），男，本科生；电子信箱：aiqiong@sjtu.edu.cn。

Research progress on the promoting effect of interleukin-11 on tumors

PAN De-shen, LI Deng, SHAO Yi   

  1. 1. Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China; 2. School of Clinical Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • Online:2020-04-28 Published:2020-05-22

PDF (PC)

589

摘要： 据最新数据统计，中国肿瘤总体发病率和死亡率与历史数据相比呈现上升趋势。深入了解肿瘤发生发展的分子机制对制定未来治疗策略十分重要。白细胞介素-11（interleukin-11，IL-11）是细胞因子中的一员，传统上被认为具有促进巨核细胞成熟和调节免疫活性的功能；但近年来，IL-11对肿瘤的促进作用逐渐被人们所发现。该文主要阐述IL-11受到转化生长因子 -β/Smad蛋白（transforming growth factor-β/drosophila mothers against decapentaplegic protein，TGF-β/Smad）通路的调控，并可能通过Janus激酶/信号转导转录激活因子（Janus kinase/signal transducer and activator of transcription，JAK/STAT）通路和磷脂酰肌醇3-激酶/蛋白激酶B（phosphatidylinositol 3 kinase/protein kinase B，PI3K/AKT）通路等信号转导途径在肿瘤发生发展、耐药、转移及肿瘤微环境中的作用，探讨干扰IL-11信号转导用于治疗肿瘤的应用前景。

关键词: 白细胞介素-11, 肿瘤微环境, TGF-&, beta, /Smad通路, JAK/STAT通路, PI3K/AKT通路

Abstract:

According to the lastest statistics, the overall morbidity and mortality of cancer in China still show an upward trend compared with historical data. An in-depth understanding of the molecular mechanisms of tumorigenesis and development is important to formulate future treatment strategies. Interleukin 11 (IL-11) is a member of cytokines that traditionally promote megakaryocyte maturation and regulate immune activity. In recent years, the promoting effect of IL-11 on tumor has been gradually discovered. This review mainly expounds that IL-11 is regulatedtransforming growth factor-β/drosophila mothers against decapentaplegic protein (TGF-β/Smad) pathway, and may play a role in tumorigenesis, drug resistance, metastasis and tumor microenvironment through signal transduction pathways such as Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) pathway, and explores the application prospect of interfering IL-11 signal transduction in tumor therapy.

Key words: interleukin-11 (IL-11), tumor microenvironment, TGF-β/Smad pathway, JAK/STAT pathway, PI3K/AKT pathway